Skip to Content

Blog

Page 3

Formula for Success: Preparing CAR T Cells for Infusion

Updated on Jul 31, 2024 By Jason Ellis, PhD

Scientists in a Lab Looking at Data on a Computer

As modern medicine continues to advance, the battle against cancer is increasingly being fought on a cellular level—and CAR T cell therapy is at the vanguard. Chimeric antigen receptor (CAR) T therapy is a remarkable form of immunotherapy that harnesses the body’s cellular defenses. It has revolutionized the treatment of malignancies such as lymphoma and blood cancers. Yet, the success of this therapy relies on more than just the genetically …

Approved CAR T Cell Therapies Revolutionize Cancer Treatment

Updated on Jan 18, 2025 By Jason Ellis, PhD

Hands Holding Colorful Cancer Awareness Ribbons

The emergence of CAR T cell therapies is one of the most promising developments in cancer treatment. This revolutionary approach, which involves reprogramming a patient’s own immune cells to fight cancer, has garnered significant attention and hope in the medical community. The recent approvals of adoptive cell therapies mark a new era in oncology and our understanding of the immune system, offering fresh avenues for patients battling various forms of …

What Is a CDMO?

Updated on Nov 17, 2023 By Jason Ellis, PhD

Two Technicians Analyzing Data on a Computer

A contract development and manufacturing organization (CDMO) is a business that provides drug development and manufacturing services to support product research, idea development, and production. New companies entering the medical or biotechnology space will face many regulatory hurdles before new products are ready for launch; and larger, more long-standing companies sometimes need additional manufacturing bandwidth. CDMOs manage multiple aspects of the product development process and guide companies through regulatory requirements …

What Is a Contract Research Organization?

Published on Oct 5, 2023 By Jason Xu, PhD

Two Scientists in Lab Coats Looking at a Computer Screen

Numerous discovery, development, and research stages exist before a new drug, pharmaceutical treatment, or medical device hits the market. Each of these stages brings unique challenges, and success depends heavily on the resources available to the sponsor of the novel treatment. Contract research organizations (CROs) provide specialized research, such as preclinical research, clinical trials, and a range of other research-based offerings, for biotechnology, pharmaceutical, and medical device companies on a …

Understanding GMP Leukopaks

Updated on Aug 7, 2024 By Dominique Badea, PhD

Two scientists conducting an experiment while wearing protective gear.

Leukopaks are an essential tool across medical and research applications, providing a robust source of white blood cells in a much higher concentration than whole blood samples. A leukopak is an enriched apheresis product collected via leukapheresis. During the leukapheresis process, white blood cells are collected and enriched by the simultaneous return of non-target blood cells to circulation. They contain a high concentration of peripheral blood mononuclear cells (PBMCs). As …

Understanding GMP in Biotech Companies

Updated on Aug 7, 2024 By Jason Ellis, PhD

Smiling Worker Holding a Tablet in a Sterile Facility

Introduction to GMP in Biotech Biotechnology sales require adherence to rules and regulations that protect both the companies and patients involved. These practices are commonly referred to in the community as GMP or good manufacturing practices. In the United States, these regulations are enacted and enforced by the Food and Drug Administration (FDA) to ensure product quality and safety. Also referred to as cGMP or current good manufacturing practices, they …

Fragile Immune Cells Require Gentle Handling

Updated on Aug 13, 2024

Immune Cells Under a Microscope

Protecting cells during cell processing is a critical aspect of protocol design and development. Cells are fragile by nature, requiring specific and gentle handling to survive and optimally perform in their downstream applications. Some cells are more delicate than others and more prone to damage or cell death when exposed to stressful conditions. The Importance of Gentle Handling Handling cells gently is crucial to maintaining cell viability, morphology, and experimental …

Dead Cell Removal

Published on Aug 22, 2023

holding a pipette, preparing culture media for cell culture science experiment

What Is Dead Cell Removal? Dead cell removal involves removing dead cells and debris from a culture or cell population to enhance purity and viability. Researchers and clinicians utilize this process in various research and clinical applications, including cell culturing, sorting, manufacturing, and cellular assays like flow cytometry. How Is Dead Cell Removal Used Across Applications? Cell culture experiments involve studying cells in a natural and controlled state. Over time, …

What Is Dead Cell Contamination?

Updated on Aug 22, 2023

Bacterial colonies culture growth on selective media.

Dead cells naturally contaminate cell samples or cultures throughout their lifespan; this contamination can occur at any time. While common, dead cells and debris negatively affect cell populations before and after separation, isolation, and application. Removing dead cells and debris before further processing plays a critical role in culture maintenance and adherence to good laboratory practices. Cell Culturing and Dead Cells Researchers grow cell cultures in the laboratory that can …

An Overview of Customized Leukopaks

Updated on Dec 9, 2024 By Brandon H. McNaughton, PhD

Red blood bag in hand scientist over white background in laboratory.

What Is a Customized Leukopak? A leukopak is a blood product enriched with white blood cells obtained through a unique extraction technique, leukapheresis. Leukapheresis, a specialized application of apheresis, targets the collection of leukocytes and returns all non-leukocyte material to the donor’s bloodstream.  Leukopaks can be customized to fit the requirements of their intended application, both clinically and for research and development. Before leukopak collection, donors are strategically selected for …

Back to Top